ULTIVA

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Cyprus, Ecuador, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ULTIVA contains one active pharmaceutical ingredient (API):

1	Remifentanil UNII 5V444H5WIC - REMIFENTANIL HYDROCHLORIDE
	Remifentanil is a selective mu-opioid agonist with a rapid onset and very short duration of action. The mu-opioid activity, of remifentanil, is antagonised by narcotic antagonists, such as naloxone.
	Read more about Remifentanil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ULTIVA Powder for concentrate for solution for infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AH06	Remifentanil	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics
Discover more medicines within N01AH06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	505618040043117, 505618040043217
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.629-1-03-12, 5918-MEE-0221
ES	Centro de información online de medicamentos de la AEMPS	61488, 61489, 61490
FI	Lääkealan turvallisuus- ja kehittämiskeskus	199505, 199612, 199661
FR	Base de données publique des médicaments	64569231, 68136868, 68201593
GB	Medicines & Healthcare Products Regulatory Agency	73122, 73125, 73128
HK	Department of Health Drug Office	43301, 43302
IL	מִשְׂרַד הַבְּרִיאוּת	7334
JP	医薬品医療機器総合機構	8219401D1021, 8219401D2028
LT	Valstybinė vaistų kontrolės tarnyba	1011444
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	541M98
NL	Z-Index G-Standaard, PRK	45713, 45721, 45748
NZ	Medicines and Medical Devices Safety Authority	7623, 7624
PL	Rejestru Produktów Leczniczych	100091092, 100091100, 100091123
SG	Health Sciences Authority	09542P
TN	Direction de la Pharmacie et du Médicament	15493051H, 15493052H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522273379, 8699874080465, 8699874080472
US	FDA, National Drug Code	67457-198, 67457-912, 67457-913, 67457-914
ZA	Health Products Regulatory Authority	31/2.9/0078, 31/2.9/0079, 31/2.9/0080